Skip to content

A Randomized Controlled Clinical Study on Dumai 'Five Points' Pricking Therapy in the Treatment of Premature Hair Graying (Blood-Heat Type)

A Randomized Controlled Clinical Study on Dumai 'Five Points' Pricking Therapy in the Treatment of Premature Hair Graying (Blood-Heat Type)

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000034710
Enrollment
Unknown
Registered
2020-07-16
Start date
2020-07-01
Completion date
Unknown
Last updated
2020-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Hair Graying

Interventions

control group:No intervention is expected and compensation treatment will be performed after the end of the study?

Sponsors

The Third Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. The clinical diagnosis is Premature Hair Graying and the Dialectics of traditional Chinese Medicine syndrome is blood-heat type (real heat syndrome with body thirst, rash spitting, irritable delirium, red tongue or silk, pulse number, etc.); 2. The age is less than 25 years old; 3. Voluntarily participate in the trial and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. White disease caused by vitiligo and other diseases; 2. Patients with platelet count < 50.000/ul or other bleeding disorders; 3. Pregnant women and lactating patients; 4. Patients with infectious diseases and diabetes; 5. Have been treated with acupuncture and other treatments within three months before the inclusion of this study; 6. At the same time participate in other clinical trials; 7. Infection or other skin disease in the treatment site affect the acupuncture operation.

Design outcomes

Primary

MeasureTime frame
Total effective rate of improving gray hair;

Secondary

MeasureTime frame
Trace elements;safety indicators;

Countries

China

Contacts

Public ContactQiwen Zhang
626938768@qq.com+86 15384027587

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026